This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
AB-FUBINACA: Difference between revisions
>Tracer m Added Category:Indazole |
>LockPicker m Format |
||
| Line 57: | Line 57: | ||
===Experience reports=== | ===Experience reports=== | ||
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_ABFUBINACA.shtml Erowid Experience Vaults: AB-FUBINACA] | |||
*[https://www.erowid.org/experiences/subs/exp_ABFUBINACA.shtml Erowid Experience Vaults: AB-FUBINACA] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 76: | Line 77: | ||
==Legal status== | ==Legal status== | ||
*''' | |||
*'''China:''' As of October 2015 AB-FUBINACA is a controlled substance in China.<ref>关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | http://www.sfda.gov.cn/WS01/CL0056/130753.html</ref> | |||
*'''Germany''' | *'''Germany:''' On December 13, 2014 AB-FUBINACA was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref> | ||
*'''Latvia:''' AB-FUBINACA is a Schedule I drug.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Indazola-3-karbonilatvasinājumi) | http://likumi.lv/doc.php?id=121086</ref> | *'''Latvia:''' AB-FUBINACA is a Schedule I drug.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Indazola-3-karbonilatvasinājumi) | http://likumi.lv/doc.php?id=121086</ref> | ||
*''' | *'''United Kingdom:''' AB-FUBINACA is a class B drug under the third-generation synthetic cannabinoids generic definition, which came into effect on the 14th December 2016 and is illegal to possess, produce, supply, or import. <ref>The Misuse of Drugs Act 1971 (Amendment) Order 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/uksi/2016/1109/made</ref> | ||
*'''United States:''' In January 2014, AB-FUBINACA was designated as a Schedule I controlled substance in the United States.<ref>Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid, 5F-PB-22 (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/24876364</ref> | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Cannabis]] | *[[Cannabis]] | ||
*[[Cannabinoid]] | *[[Cannabinoid]] | ||
*[[THJ-018]] | *[[THJ-018]] | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/AB-FUBINACA AB-FUBINACA (Wikipedia)] | *[https://en.wikipedia.org/wiki/AB-FUBINACA AB-FUBINACA (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=2634 AB-FUBINACA (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=2634 AB-FUBINACA (Isomer Design)] | ||
===Discussion=== | ===Discussion=== | ||
*[https://www.ukchemicalresearch.org/Thread-AB-FUBINACA AB-FUBINACA (UKCR)] | *[https://www.ukchemicalresearch.org/Thread-AB-FUBINACA AB-FUBINACA (UKCR)] | ||
==References== | ==References== | ||
<references/> | <references /> | ||
{{#set:Featured=true}} | {{#set:Featured=true}} | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Indazole]] | [[Category:Indazole]] | ||
[[Category:Cannabinoid]] | [[Category:Cannabinoid]] | ||